012－9365－z．［30］HANAIT，SHIＲAKIM，WATANABES，etal．Sarcopeniapredictsminimalhepaticencephalopathyinpatientswithlivercirrhosis［J］．HepatolＲes，2017，47(13):1359－1367．DOI:10．1111/hepr．12873．［31］NAＲDELLIS，ＲIGGIOO，GIOIAS，etal．Ｒiskfactorsforhepaticencephalopathyandmortalityincirrhosis:Theroleofcognitiveimpairment，musclealterationsandshunts［J］．DigLiverDis，2022，54(8):1060－1065．DOI:10．1016/j．dld．2021．12．015．［32］HANAIT，NISHIMUＲAK，MIWAT，etal．Usefulnessofnu-tritionaltherapyrecommendedintheJapaneseSocietyofGastroenterology/JapanSocietyofHepatologyevidence－basedclinicalpracticeguidelinesforlivercirrhosis2020［J］．JGastroenterol，2021，56(10):928－937．DOI:10．1007/s00535－021－01821－z．［33］NAＲDELLIS，GIOIAS，PASQUALEC，etal．Cognitiveimpairmentpredictstheoccurrenceofhepaticencepha-lopathyaftertransjugularintrahepaticportosystemicshunt［J］．AmJGastroenterol，2016，111(4):523－528．DOI:10．1038/ajg．2016．29．［34］CAIW，LINH，QIＲ，etal．Psoasmuscledensitypredictsoccurrencesofhepaticencephalopathyinpatientsreceiv-ingtransjugularintrahepaticportosystemicshuntswithin1year［J］．CardiovascInterventＲadiol，2022，45(1):93－101．DOI:10．1007/s00270－021－02961－8．［35］GIOIAS，ＲIDOLAL，CＲISTOFAＲOL，etal．Theimprovementinbodycompositionincludingsubcuta-neousandvisceralfatreducesammoniaandhepaticen-cephalopathyaftertransjugularintrahepaticportosystemicshunt［J］．LiverInt，2021，41(12):2965－2973．DOI:10．1111/liv．15060．［36］YANGC，ZHUX，LIUJ，etal．Developmentandvalidationofprognosticmodelstoestimatetheriskofoverthepaticen-cephalopathyafterTIPScreation:Amulticenterstudy［J］．ClinTranslGastroenterol，2022，13(3):e00461．DOI:10．14309/ctg．0000000000000461．［37］ZENGX，SHIZW，YUJJ，etal．Sarcopeniaasaprognosticpredictoroflivercirrhosis:amulticentrestudyinChina［J］．JCachexiaSarcopeniaMuscle，2021，12(6):1948－1958．DOI:10．1002/jcsm．12797．［38］KUMAＲA，DAVULUＲIG，SILVAＲNE，etal．Ammonialoweringreversessarcopeniaofcirrhos...
